+61 2-8964 9600 info@lucidhealthcon.com
  • Twitter
  • Linkedin
  • Twitter
  • Linkedin
Lucid Health Consulting
  • HOME
  • ABOUT
  • SERVICES
    • Reimbursement Submissions – PBAC and MSAC
    • Economic Evaluations
    • Statistical Analyses
    • Regulatory Strategy, Submissions & Compliance
    • Commercial Strategy
  • TEAM
  • ARTICLES
  • PUBLICATIONS
  • VIDEOS
  • CONTACT
Select Page
Should discount rates be selectively applied in health economic evaluations?

Should discount rates be selectively applied in health economic evaluations?

by George Papadopoulos | Sep 7, 2020 | Discount rates and Economic Evaluations

Authors: Hemant Rathi1 and George Papadopoulos2,3 Skyward Analytics Pte. Ltd., Singapore Lucid Heath Consulting Pty. Ltd., Australia University of New South Wales, School of Medicine, Australia Disclaimer: All opinions expressed in the article are personal  ...
ISPOR VOS Research Round Up | July-August 2020.

ISPOR VOS Research Round Up | July-August 2020.

by George Papadopoulos | Sep 1, 2020 | ISPOR Values & Outcomes SPOTLIGHT

Our Director, George Papadopoulos, authored the ISPOR  Research Roundup in the July-August 2020 Edition of the Value & Outcomes Spotlight. George’s article identifies the interface between experimental and behavioural economics and health economics by identifying...

Recent Posts

  • Submission to the Consultation on the Medical Services Advisory Committee (MSAC)
  • Lucid Health Consulting enters strategic agreement with MAOSS – for Australian Market Access Data
  • ISPOR VOS Research Round Up | September – October 2020.

Recent Comments

  • admin on Should discount rates be selectively applied in health economic evaluations?
  • Tim Hortons Buffalo on Should discount rates be selectively applied in health economic evaluations?

Archives

  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • July 2020
  • Twitter
  • Linkedin
Created by Spindrift Marketing| © Lucid Health Consulting 2020